Home › Wisconsin › Bills
Bills

Wisconsin Congressional Bills

Browse federal bills sponsored by your state's delegation.

Bill results

in committee · Wisconsin · House Feb 3, 2021

HR 764: Keep Our PACT Act

Keep Our Promise to America's Children and Teachers Act or the Keep Our PACT Act This bill provides funding through FY2031 for grant programs operated by local educational agencies to provide supplementary educational and related services to low-achieving students and other students who attend elementary and secondary schools with relatively high concentrations of students from low-income families. Additionally, the bill permanently reauthorizes the grant program to assist states and outlying areas in providing special education and related services to children with disabilities.
Susie Lee (D) · 63 co-sponsors
in committee · Wisconsin · House Feb 3, 2021

HR 766: TAILOR Act

Taking Account of Institutions with Low Operation Risk Act or the TAILOR Act This bill requires federal financial regulatory agencies to (1) tailor any regulatory actions so as to limit burdens on the institutions involved, with consideration of the risk profiles and business models of those institutions; and (2) report to Congress on specific actions taken to do so, as well as on other related issues. The bill's tailoring requirement applies not only to future regulatory actions but also to regulations adopted within the last seven years.
Barry Loudermilk (R) · 12 co-sponsors
in committee · Wisconsin · House Feb 3, 2021

HR 708: TREAT Act

Temporary Reciprocity to Ensure Access to Treatment Act or the TREAT Act This bill temporarily authorizes the interstate provision of in-person and telehealth services. This authorization applies during, and for at least 180 days after, the COVID-19 (i.e., coronavirus disease 2019) emergency. Specifically, subject to scope of practice and other requirements, a health care professional may provide health services in any U.S. jurisdiction based on that individual's authorization to practice in any one state or territory. The bill also provides certain related powers to health care professional regulatory bodies, such as medical boards. Specifically, a regulatory body may investigate and take disciplinary actions against a professional who provides services pursuant to this bill to a patient in that body's jurisdiction.
Robert E. Latta (R) · 41 co-sponsors
in committee · Wisconsin · House Feb 3, 2021

HR 726: COVID–19 Testing, Reaching, And Contacting Everyone (TRACE) Act

COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act This bill authorizes the Centers for Disease Control and Prevention to award grants for testing, contact tracing, monitoring, and other activities to address COVID-19 (i.e., coronavirus disease 2019). Entities eligible for these grants include certain clinics and hospitals, nonprofits, and schools.
Bobby L. Rush (D) · 34 co-sponsors
in committee · Wisconsin · House Feb 2, 2021

HRES 81: Expressing the opposition of the House of Representatives of providing the vaccination for COVID-19 for detainees at the detention facility at United States Naval Station, Guantanamo Bay, Cuba, before American citizens receive such vaccination.

This resolution expresses the opposition of the House of Representatives to any plans by the Department of Defense to deliver COVID-19 (i.e., coronavirus disease 2019) vaccines to prisoners held at United States Naval Station, Guantanamo Bay, Cuba, until all Americans have had the opportunity to be vaccinated. Additionally, the resolution asserts that the government should prioritize U.S. citizens for COVID-19 vaccinations.
Elise M. Stefanik (R) · 62 co-sponsors
in committee · Wisconsin · Senate Feb 2, 2021

S 146: Medical Bankruptcy Fairness Act of 2021

Medical Bankruptcy Fairness Act of 2021 This bill allows medically distressed debtors to exempt certain property from their estates in bankruptcy, which allows them to retain ownership of such property. Specifically, a medically distressed debtor may exempt up to $250,000 of the debtor's interest in (1) specified real or personal property that the debtor or debtor's dependent uses as a residence, or (2) a burial plot for the debtor or debtor's dependent. The bill also waives certain administrative and procedural requirements for a medically distressed debtor. Additionally, the bill allows a medically distressed debtor to discharge in bankruptcy debts for certain education loans. A debtor who seeks relief as a medically distressed debtor must attest in writing that the debtor's medical expenses are genuine and were not incurred to bring the debtor within the meaning of a medically distressed debtor under this bill.
Sheldon Whitehouse (D) · 4 co-sponsors
in committee · Wisconsin · Senate Feb 2, 2021

S 179: A bill to authorize the appropriation of an additional $10,000,000,000 to secure critical materials and supplies to combat the COVID-19 pandemic.

This bill authorizes the Department of Health and Human Services (HHS) to secure critical supplies to combat COVID-19 (i.e., coronavirus disease 2019). In securing these supplies, HHS must coordinate with the Department of Defense and the Department of Homeland Security. HHS may also use authorities available under the Defense Production Act of 1950 to secure supplies. That act confers upon the President a broad set of authorities to influence domestic industries to provide essential materials and goods needed for the national defense.
Tammy Baldwin (D) · 1 co-sponsor
in committee · Wisconsin · Senate Feb 2, 2021

S 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 This bill establishes a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country and there is an unmet need. Specifically, the bill requires the product's sponsor to demonstrate, among other things, that (1) the product has been approved in one of the specified countries, (2) neither the FDA nor any of the specified countries have withdrawn approval for the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may decline approval if the FDA determines that the product is not safe or effective. The FDA may condition reciprocal approval on the conduct of postmarket studies. The FDA must issue a decision on whether to grant a request for reciprocal marketing approval within 30 days of receiving the request. Congress may pass a joint resolution to grant reciprocal marketing approval of a product that the FDA declines to approve through the reciprocal process.
Ted Cruz (R) · 3 co-sponsors
in committee · Wisconsin · Senate Feb 2, 2021

S 147: CARES Windfall for the Wealthiest Repeal Act

CARES Windfall for the Wealthiest Repeal Act This bill restores and makes permanent the limitation on excess businesses losses of noncorporate taxpayers. It also allows taxpayers a carryback of their net operating losses arising in 2019 and 2020.
Sheldon Whitehouse (D) · 16 co-sponsors
Showing 7,873 to 7,884 of 8,022 bills